Shares of Semler Scientific Inc. (SMLR), a commercial-stage medical device company, are down over 80% from their 52-week high of $53.38, recorded in February of this year, and trade around $29.
The company's flagship product is QuantaFlo, a patented, FDA-cleared point-of-care product designed to assess arterial blood flow in the extremities swiftly. QuantaFlo supports health care providers in the early diagnosis of peripheral arterial disease, even in patients who are asymptomatic.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com